PMID: 2110431May 1, 1990Paper

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

Annals of Internal Medicine
P E Love, S A Santoro

Abstract

To determine the prevalence of lupus anticoagulant and anticardiolipin in systemic lupus erythematosus (SLE) and in non-SLE disorders, and to evaluate the clinical significance of these autoantibodies as they relate to thromboembolic events, neuropsychiatric disorders, thrombocytopenia, and fetal loss. A computer-assisted search of the literature (MEDLINE, 1966 to 1989) and review of the bibliographies of all identified articles. Series of ten or more subjects were included if the assays used for detecting lupus anticoagulant or anticardiolipin met the specified minimal criteria for validity. Series were categorized according to antibody type and underlying disease. A systematic appraisal of patient selection methods, study design, and assay methods was done. An analysis of 29 published series (comprising over 1000 patients with SLE) yielded an average frequency of 34% for the lupus anticoagulant and 44% for anticardiolipin. Antiphospholipid antibodies are also prevalent in patients with various non-SLE disorders. In patients with SLE, a statistically significant association exists between the presence of either antibody and a history of thrombosis, neurologic disorders, or thrombocytopenia. The available data suggest, but do n...Continue Reading

Citations

Feb 14, 1998·American Journal of Hematology·I S LossosY Matzner
Dec 22, 1999·American Journal of Hematology·J F ViallardM Parrens
May 20, 1999·Cytometry·K A DrouvalakisR R Buchanan
Mar 4, 1998·Arthritis and Rheumatism·A A ManfrediM G Sabbadini
Jul 12, 2002·American Journal of Hematology·Jodi B SegalThomas S Kickler
Feb 1, 1993·American Journal of Hematology·R SaxenaO P Malhotra
Apr 1, 1993·American Journal of Hematology·O KucukM P Westerman
Sep 26, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·H S SingerL S Kiessling
Nov 1, 1995·Journal of Clinical Immunology·D B Cines, K R McCrae
Jul 1, 1994·European Journal of Pediatrics·A RavelliG R Burgio
Jul 1, 1994·Digestive Diseases and Sciences·P ChamouardR Baumann
Jun 1, 1994·Digestive Diseases and Sciences·M S CappellN Gujral
Mar 1, 1995·Clinical Rheumatology·R M McLean, T P Greco
Sep 1, 1996·Clinical Rheumatology·Y MatsukawaT Takasu
May 1, 1996·Clinical Rheumatology·S Praprotnik, B Bozic
Jun 1, 1993·Clinical Rheumatology·H A MesaH H Peter
Sep 1, 1993·Clinical Rheumatology·A K al-MomenL al-Nuaim
Jul 1, 1995·Digestive Diseases and Sciences·J C SoutoM Roca
Apr 25, 2000·Indian Journal of Pediatrics·A Kakar, P K Sethi
Jan 1, 1995·Clinical Reviews in Allergy & Immunology·J P ViardJ F Bach
Jan 1, 1995·Clinical Reviews in Allergy & Immunology·J C PietteB Wechsler
Nov 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P R Howell, M J Douglas
Sep 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S R Davies

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2021 Meta ULC. All rights reserved